Expert: PARP1-selective inhibitor designed to minimize PARP2-mediated hematological toxicity while maintaining synthetic lethality in HRD tumors.
Everyday: A more targeted version of PARP inhibitors that may have fewer side effects.
Targets: ["PARP1"]